Annual Retained Earnings
-$1.21 B
-$160.93 M-15.31%
December 31, 2023
Summary
- As of February 7, 2025, FATE annual retained earnings is -$1.21 billion, with the most recent change of -$160.93 million (-15.31%) on December 31, 2023.
- During the last 3 years, FATE annual retained earnings has fallen by -$654.80 million (-117.57%).
- FATE annual retained earnings is now -2258.56% below its all-time high of -$51.38 million, reached on December 31, 2011.
Performance
FATE Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.35 B
-$47.68 M-3.67%
September 30, 2024
Summary
- As of February 7, 2025, FATE quarterly retained earnings is -$1.35 billion, with the most recent change of -$47.68 million (-3.67%) on September 30, 2024.
- Over the past year, FATE quarterly retained earnings has dropped by -$178.23 million (-15.26%).
- FATE quarterly retained earnings is now -1951.12% below its all-time high of -$65.61 million, reached on December 31, 2012.
Performance
FATE Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
FATE Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.3% | -15.3% |
| 3 y3 years | -117.6% | -25.8% |
| 5 y5 years | -324.6% | -222.7% |
FATE Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.6% | at low | -75.0% | at low |
| 5 y | 5-year | -215.9% | at low | -250.9% | at low |
| alltime | all time | -2258.6% | at low | -1951.1% | at low |
Fate Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$1.35 B(+3.7%) |
| Jun 2024 | - | -$1.30 B(+3.1%) |
| Mar 2024 | - | -$1.26 B(+4.0%) |
| Dec 2023 | -$1.21 B(+15.3%) | -$1.21 B(+3.8%) |
| Sep 2023 | - | -$1.17 B(+4.0%) |
| Jun 2023 | - | -$1.12 B(+4.9%) |
| Mar 2023 | - | -$1.07 B(+1.8%) |
| Dec 2022 | -$1.05 B(+36.6%) | -$1.05 B(+5.7%) |
| Sep 2022 | - | -$994.44 M(+9.2%) |
| Jun 2022 | - | -$910.88 M(+9.1%) |
| Mar 2022 | - | -$834.77 M(+8.5%) |
| Dec 2021 | -$769.08 M(+38.1%) | -$769.08 M(+9.8%) |
| Sep 2021 | - | -$700.46 M(+6.6%) |
| Jun 2021 | - | -$657.15 M(+9.2%) |
| Mar 2021 | - | -$602.02 M(+8.1%) |
| Dec 2020 | -$556.93 M(+45.2%) | -$556.93 M(+10.5%) |
| Sep 2020 | - | -$503.82 M(+13.2%) |
| Jun 2020 | - | -$445.14 M(+6.7%) |
| Mar 2020 | - | -$417.06 M(+8.7%) |
| Dec 2019 | -$383.55 M(+34.4%) | -$383.55 M(+8.0%) |
| Sep 2019 | - | -$355.24 M(+8.1%) |
| Jun 2019 | - | -$328.63 M(+7.7%) |
| Mar 2019 | - | -$305.16 M(+6.9%) |
| Dec 2018 | -$285.40 M | -$285.40 M(+5.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -$269.37 M(+6.6%) |
| Jun 2018 | - | -$252.59 M(+8.4%) |
| Mar 2018 | - | -$232.93 M(+6.5%) |
| Dec 2017 | -$218.80 M(+24.4%) | -$218.80 M(+6.1%) |
| Sep 2017 | - | -$206.30 M(+5.5%) |
| Jun 2017 | - | -$195.62 M(+5.2%) |
| Mar 2017 | - | -$185.97 M(+5.8%) |
| Dec 2016 | -$175.85 M(+23.5%) | -$175.85 M(+4.7%) |
| Sep 2016 | - | -$167.91 M(+5.5%) |
| Jun 2016 | - | -$159.17 M(+5.6%) |
| Mar 2016 | - | -$150.76 M(+5.9%) |
| Dec 2015 | -$142.38 M(+26.7%) | -$142.38 M(+5.5%) |
| Sep 2015 | - | -$134.94 M(+5.4%) |
| Jun 2015 | - | -$128.05 M(+6.5%) |
| Mar 2015 | - | -$120.27 M(+7.0%) |
| Dec 2014 | -$112.39 M(+29.9%) | -$112.39 M(+5.9%) |
| Sep 2014 | - | -$106.16 M(+6.6%) |
| Jun 2014 | - | -$99.56 M(+6.5%) |
| Mar 2014 | - | -$93.49 M(+8.1%) |
| Dec 2013 | -$86.51 M(+31.8%) | -$86.51 M(+7.1%) |
| Sep 2013 | - | -$80.77 M(+7.7%) |
| Jun 2013 | - | -$74.97 M(+14.3%) |
| Dec 2012 | -$65.61 M(+27.7%) | -$65.61 M |
| Dec 2011 | -$51.38 M | - |
FAQ
- What is Fate Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Fate Therapeutics?
- What is Fate Therapeutics annual retained earnings year-on-year change?
- What is Fate Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Fate Therapeutics?
- What is Fate Therapeutics quarterly retained earnings year-on-year change?
What is Fate Therapeutics annual retained earnings?
The current annual retained earnings of FATE is -$1.21 B
What is the all time high annual retained earnings for Fate Therapeutics?
Fate Therapeutics all-time high annual retained earnings is -$51.38 M
What is Fate Therapeutics annual retained earnings year-on-year change?
Over the past year, FATE annual retained earnings has changed by -$160.93 M (-15.31%)
What is Fate Therapeutics quarterly retained earnings?
The current quarterly retained earnings of FATE is -$1.35 B
What is the all time high quarterly retained earnings for Fate Therapeutics?
Fate Therapeutics all-time high quarterly retained earnings is -$65.61 M
What is Fate Therapeutics quarterly retained earnings year-on-year change?
Over the past year, FATE quarterly retained earnings has changed by -$178.23 M (-15.26%)